Jos Rijntjes

1.2k total citations
24 papers, 777 citations indexed

About

Jos Rijntjes is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Jos Rijntjes has authored 24 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Jos Rijntjes's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Glioma Diagnosis and Treatment (4 papers). Jos Rijntjes is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Glioma Diagnosis and Treatment (4 papers). Jos Rijntjes collaborates with scholars based in Netherlands, Germany and France. Jos Rijntjes's co-authors include Pieter Wesseling, Patricia J.T.A. Groenen, D. van Dorp, Eddy van der Maarel, Goos N.P. van Muijen, Angelique Sijben, Sandra Boots‐Sprenger, Judith W. M. Jeuken, Willeke A.M. Blokx and Nicole de Wit and has published in prestigious journals such as Bioinformatics, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Jos Rijntjes

24 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jos Rijntjes Netherlands 14 261 258 229 174 140 24 777
E Nacheva United Kingdom 17 463 1.8× 265 1.0× 325 1.4× 233 1.3× 92 0.7× 28 1.1k
Lionel Coignet France 21 530 2.0× 253 1.0× 280 1.2× 262 1.5× 95 0.7× 42 1.1k
D Jadayel United Kingdom 14 420 1.6× 334 1.3× 375 1.6× 421 2.4× 86 0.6× 21 1.1k
Monika Szczepanowski Germany 20 328 1.3× 309 1.2× 574 2.5× 750 4.3× 106 0.8× 50 1.2k
Ana M Muñoz‐Mármol Spain 18 504 1.9× 124 0.5× 184 0.8× 155 0.9× 70 0.5× 45 921
Alyssa Morimoto United States 18 631 2.4× 168 0.7× 234 1.0× 154 0.9× 99 0.7× 29 1.3k
Christian J. Davidson United States 9 383 1.5× 422 1.6× 227 1.0× 64 0.4× 312 2.2× 17 930
J.P. Magaud France 14 430 1.6× 203 0.8× 295 1.3× 379 2.2× 70 0.5× 21 988
Sadie Johnson United States 19 369 1.4× 118 0.5× 234 1.0× 47 0.3× 110 0.8× 60 859
Cristina López Spain 19 270 1.0× 293 1.1× 150 0.7× 287 1.6× 57 0.4× 43 908

Countries citing papers authored by Jos Rijntjes

Since Specialization
Citations

This map shows the geographic impact of Jos Rijntjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Rijntjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Rijntjes more than expected).

Fields of papers citing papers by Jos Rijntjes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Rijntjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Rijntjes. The network helps show where Jos Rijntjes may publish in the future.

Co-authorship network of co-authors of Jos Rijntjes

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Rijntjes. A scholar is included among the top collaborators of Jos Rijntjes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Rijntjes. Jos Rijntjes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Helden-Meeuwsen, Cornelia G van, Paul Van Daele, Zana Brkić, et al.. (2023). Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics. Frontiers in Oncology. 13. 1130686–1130686. 4 indexed citations
2.
Rijntjes, Jos, Annemiek B. van Spriel, Ellen van der Spek, et al.. (2023). Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. HemaSphere. 7(11). e976–e976. 4 indexed citations
3.
Kroeze, Leonie I., Blanca Scheijen, Konnie M. Hebeda, et al.. (2022). PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(1). 105–110. 4 indexed citations
4.
Kroeze, Leonie I., Jos Rijntjes, Konnie M. Hebeda, et al.. (2021). Multiple Immunoglobulin κ Gene Rearrangements within a Single Clone Unraveled by Next-Generation Sequencing–Based Clonality Assessment. Journal of Molecular Diagnostics. 23(9). 1097–1104. 4 indexed citations
5.
Brand, Michiel van den, Jos Rijntjes, Markus Möbs, et al.. (2021). Next-Generation Sequencing–Based Clonality Assessment of Ig Gene Rearrangements. Journal of Molecular Diagnostics. 23(9). 1105–1115. 23 indexed citations
6.
Brand, Michiel van den, Jos Rijntjes, Konnie M. Hebeda, et al.. (2021). Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Modern Pathology. 35(6). 757–766. 12 indexed citations
7.
Scheijen, Blanca, Ruud W. J. Meijers, Jos Rijntjes, et al.. (2019). Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS. Leukemia. 33(9). 2227–2240. 79 indexed citations
8.
Brand, Michiel van den, Jos Rijntjes, Konnie M. Hebeda, et al.. (2016). Recurrent mutations in genes involved in nuclear factor‐κB signalling in nodal marginal zone lymphoma—diagnostic and therapeutic implications. Histopathology. 70(2). 174–184. 17 indexed citations
9.
Appenzeller, Silke, Christian Gilissen, Jos Rijntjes, et al.. (2015). Immunoglobulin rearrangement analysis from multiple lesions in the same patient using next‐generation sequencing. Histopathology. 67(6). 843–858. 4 indexed citations
10.
Grunsven, Adriana C. H. van Engen–van, Marjolein P. Baar, Rolph Pfundt, et al.. (2015). Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas. Melanoma Research. 25(3). 200–209. 13 indexed citations
11.
Grunsven, Adriana C. H. van Engen–van, Heidi V.N. Küsters‐Vandevelde, Joanne A. de Hullu, et al.. (2014). NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract—A study of 24 cases from the Netherlands. Gynecologic Oncology. 134(1). 10–14. 29 indexed citations
12.
Küsters‐Vandevelde, Heidi V.N., Annelieke E.C.A.B. Willemsen, Patricia J.T.A. Groenen, et al.. (2014). Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor. Acta Neuropathologica Communications. 2(1). 41–41. 45 indexed citations
13.
Boots‐Sprenger, Sandra, Angelique Sijben, Jos Rijntjes, et al.. (2013). Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution. Modern Pathology. 26(7). 922–929. 83 indexed citations
14.
Jeuken, Judith W. M., Angelique Sijben, Fonnet E. Bleeker, et al.. (2010). The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic “Life Story”. Brain Pathology. 21(3). 308–320. 17 indexed citations
15.
Feuth, Ton, John Raemaekers, Jos Rijntjes, et al.. (2010). Protein profiling in pathology: Analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B‐cell lymphomas. PROTEOMICS - CLINICAL APPLICATIONS. 4(5). 519–527. 7 indexed citations
16.
Kempen, Léon C.L.T. van, Jos Rijntjes, Silvia Vincent‐Naulleau, et al.. (2007). Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma. International Journal of Cancer. 122(5). 1019–1029. 61 indexed citations
17.
Kempen, Léon C.L.T. van, Jos Rijntjes, Silvia Vincent‐Naulleau, et al.. (2006). Type I collagen turnover is a critical parameter for melanoma progression. Melanoma Research. 16(Supplement 1). S71–S71. 2 indexed citations
18.
Wit, Nicole de, Jos Rijntjes, J H S Diepstra, et al.. (2005). Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. British Journal of Cancer. 92(12). 2249–2261. 85 indexed citations
19.
Kempen, Léon C.L.T. van, et al.. (2004). Type I collagen synthesis parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell carcinoma. The Journal of Pathology. 204(3). 333–339. 18 indexed citations
20.
Erp, P.E.J. van, et al.. (1984). Fucosyl Glycopeptide Profiles of Keratinocytes from Various Epithelial Tissues of the Rabbit in Relation to Differentiation In Vivo and In Vitro. Journal of Investigative Dermatology. 83(5). 359–362. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026